The genome tells the real story of a transplant. Our work is to read that story clearly, quantify it honestly, and put it within reach of the clinicians and patients who depend on it.
Genomics has changed what a diagnostic can see. Yet in transplant medicine many everyday decisions still rest on invasive procedures, on tests that cost thousands and run only in central laboratories, or on measurements that shift from one machine and one day to the next.
The result is a gap between what is scientifically possible and what actually reaches the bedside. Closing that gap is our reason to exist.
We measure biology at its native level of detail, reading the molecular signal directly instead of inferring it from an ageing surrogate.
Calibrated, quantitative results that travel between laboratories and hold their meaning over time, with uncertainty stated plainly.
Engineered to run beyond the central laboratory, so clearer answers are not a privilege of geography or budget.
Scira's diagnostic programmes are advancing through design and validation. We will share detail here as each is ready, and only when the evidence supports it. If you are a clinical, research or commercial partner, we would welcome an early conversation.
